NCT07631650: Bevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Thyroidectomy Patients
- State
- Under way
- Phase
- Phase 2
- People
- 40 planned
- Started
- 4 Nov 2026
- Primary completion
- 4 Nov 2027
- Arms
- Bevonescein (ALM 488) Infusion
- Results
- None posted
- 8 Jun 2026: Trial registered
- 4 Nov 2026: Trial started